acetylglucosamine has been researched along with Stroke in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
| Jiang, M; Li, Y; Liu, S; Paschen, W; Sheng, H; Warner, DS; Yang, W; Yu, S; Yu, Z | 1 |
| Cheng, Q; Chi, X; Ding, F; Wei, L; Xu, H; Yang, Y; Yu, S; Zhou, C | 1 |
| Abe, K; Feng, T; Fukui, Y; Hasumi, K; Hishikawa, N; Huang, Y; Liu, X; Morihara, R; Nakano, Y; Ohta, Y; Sato, K; Shang, J; Shi, X; Suzuki, E; Takemoto, M; Yamashita, T | 1 |
| Cheng, Q; Ding, F; Li, L; Liu, M; Yang, Y; Yu, S | 1 |
| Liu, S; Paschen, W; Sheng, H; Yang, W; Yu, Z | 1 |
| Ding, F; Liu, X; Shen, Y; Xu, H; Yang, Y; Yu, S | 1 |
| Hao, J; He, Y; Li, D; Ma, X | 1 |
1 review(s) available for acetylglucosamine and Stroke
| Article | Year |
|---|---|
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
7 other study(ies) available for acetylglucosamine and Stroke
| Article | Year |
|---|---|
XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G.
Topics: Acetylglucosamine; Age Factors; Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotection; Protein Folding; Protein Serine-Threonine Kinases; Pyrans; Stroke; Thiazoles; Unfolded Protein Response; X-Box Binding Protein 1 | 2017 |
2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-β-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury.
Topics: Acetylglucosamine; Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Glucose; Male; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Stroke | 2018 |
Neuroprotective effects of SMTP-44D in mice stroke model in relation to neurovascular unit and trophic coupling.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Vessels; Brain Infarction; Brain-Derived Neurotrophic Factor; Calcium-Binding Proteins; Caspase 3; DNA-Binding Proteins; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred ICR; Microfilament Proteins; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Oxidative Stress; Phenols; Pyroptosis; Stachybotrys; Stroke; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha | 2018 |
2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3.
Topics: Acetylglucosamine; Animals; Brain Ischemia; Calpain; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Glucose Transporter Type 3; Hippocampus; Mice; Molecular Structure; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke | 2014 |
O-linked β-N-acetylglucosamine modification of proteins is activated in post-ischemic brains of young but not aged mice: Implications for impaired functional recovery from ischemic stress.
Topics: Acetylglucosamine; Aging; Animals; Brain; Brain Ischemia; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Protein Processing, Post-Translational; Psychomotor Performance; Recovery of Function; Stress, Physiological; Stroke; SUMO-1 Protein; Ubiquitination; Unfolded Protein Response | 2016 |
Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Topics: Acetylglucosamine; Animals; Brain; Cerebral Hemorrhage; Combined Modality Therapy; Disease Models, Animal; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats, Sprague-Dawley; Recovery of Function; Stroke; Tissue Plasminogen Activator | 2016 |
Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Biomarkers; Disease Models, Animal; Macrophages; Male; Mice, Inbred C57BL; Microglia; N-Acetylglucosaminyltransferases; Neuroprotective Agents; Pyrans; Signal Transduction; Stroke; Thiazoles; Transcription Factor RelA | 2017 |